Also listed on Mallinckrodt Critical Care Finance Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends no later than Jun 30, 2029 · Low confidence
20-year base term ends Jun 30, 2029
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Jun 30, 2009
Jun 30, 2029
Oct 9, 2012
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 30, 2009, when application 12/494,598, the earliest non-provisional in its chain, was filed (this one was filed Jun 22, 2010); a parent in its chain could not be resolved (the next row) | Jun 30, 2029 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Jun 30, 2029 | Low confidence |
This family
| Application 12/494,598 | Abandoned not computed | not computed |
| Application PCT/US2010/038652 | PCT application no patent term | no patent term |
| Application 12/820,866 | Abandoned not computed | not computed |
| Application 12/820,980 | Abandoned not computed | not computed |
| US 8,282,966 | this patent no later than Jun 2029 | no later than Jun 2029 |
| US 8,293,284 | In force no later than Jun 2029 | no later than Jun 2029 |
| US 8,431,163 | In force Jun 2029 | Jun 2029 |
| US 8,846,112 | In force Jun 2029 | Jun 2029 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Enterprises Holdings LLC (F/K/A Mallinckrodt Enterprises Holdings, Inc.) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Enterprises LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Lafayette Pharmaceuticals LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Liebel-Flarsheim Company LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Brand Pharmaceuticals LLC (F/K/A Mallinckrodt Brand Pharmaceuticals, Inc.) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Veterinary, Inc. | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt US Holdings LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Imc Exploration Company | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Meh, Inc. | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Hospital Products IP Unlimited Company (F/K/A Mallinckrodt Hospital Products IP Limited) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Ard IP Unlimited Company (F/K/A Mallinckrodt Ard IP Limited) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Ocera Therapeutics LLC (F/K/A Ocera Therapeutics, Inc.) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Specgx LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Stratatech Corporation | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Sucampo Pharma Americas LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Vtesse LLC (F/K/A Vtesse Inc.) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Pharmaceuticals Ireland Limited | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Pharma IP Trading Unlimited Company (F/K/A Mallinckrodt Pharma IP Trading D.A.C.) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Infacare Pharmaceutical Corporation | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | ST Shared Services LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Therakos, Inc. | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Ikaria Therapeutics LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Ino Therapeutics LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Aug 1, 2025 Reel 72331, frame 1 | Mallinckrodt Pharmaceuticals Ireland Limited | Computershare Trust Company, National Association | Security Interest |
| Aug 14, 2025 Reel 72324, frame 740 | Acquiom Agency Services LLC | Mallinckrodt Enterprises LLC; Mallinckrodt LLC; Mallinckrodt Pharma IP Trading Unlimited Company; Mallinckrodt Pharmaceuticals Ireland Limited; Ocera Therapeutics LLC; Specgx LLC; Stratatech Corporation; Sucampo Pharma Americas LLC; Vtesse LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt Enterprises LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt Pharma IP Trading Unlimited Company | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt Pharmaceuticals Ireland Limited | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Ocera Therapeutics LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Specgx LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Stratatech Corporation | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Sucampo Pharma Americas LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Vtesse LLC | Release of Security Interest |
| Oct 28, 2025 Reel 73375, frame 395 | Mallinckrodt Pharmaceuticals Ireland Limited | Goldman Sachs Bank USA, as Administrative Agent | Security Interest |
| Mar 6, 2026 Reel 75021, frame 263 | Mallinckrodt Pharmaceuticals Ireland Limited | Goldman Sachs Bank USA, as Administrative Agent | Corrective Assignment to Correct the Inclusion of US Patent 10828415 and Remove It from the Listing Previously Recorded on Reel 73375 Frame 395. Assignor(S) Hereby Confirms the Security Interest. |
| Mar 6, 2026 Reel 75021, frame 204 | Mallinckrodt Pharmaceuticals Ireland Limited | Computershare Trust Company, National Association | Corrective Assignment to Correct the Inclusion of US Patent 10828415 and Remove It from the Listing Previously Recorded on Reel 72331 Frame 1. Assignor(S) Hereby Confirms the Security Interest. |
| Apr 10, 2026 Reel 75393, frame 361 | Mallinckrodt Hospital Products IP Unlimited Company | Mallinckrodt Pharmaceuticals Ireland Limited Company | Assignment of Assignor's Interest |
| Sep 25, 2026 Reel 76580, frame 1 | Mallinckrodt Hospital Products IP Unlimited Company | Mallinckrodt Pharmaceuticals Ireland Limited | Corrective Assignment to Correct the Name of the Assignee Mallinckrodt Pharmaceuticals Ireland Limited Previously Recorded on Reel 75393 Frame 361. Assignor(S) Hereby Confirms the Assignment. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Jun 30, 2029. We will not guess the cap.